David A Mareska

This inventor holds 24 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Array Biopharma Inc., Knopp Biosciences, LLC, Biohaven Therapeutics Ltd.. Active years: 2006-2025.

USPTO Granted Patents = 24 (Patent Applications = 10)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 513(Granted Patents)

Location History:

Longmont, CO (US) (2006 - 2009)
Boulder, CO (US) (2010 - 2015)
McMurray, PA (US) (2014 - 2023)
Pittsburgh, PA (US) (2023)

Company Filing History:

Knopp Biosciences, LLC

patents

4 out of 32

Biohaven Therapeutics Ltd.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators (2025-07-08),

2. 12286408 - KV7 channel activators compositions and methods of use (2025-04-29),

3. 11834418 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2023-12-05),

4. 11724990 - Kv7 channel activators compositions and methods of use (2023-08-15),

5. 11261162 - KV7 channel activators compositions and methods of use (2022-03-01),

6. 10906877 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2021-02-02),

7. 10851067 - Kv7 channel activators compositions and methods of use (2020-12-01),

8. 10669269 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2020-06-02),

9. 10526328 - Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators (2020-01-07),

10. 10385025 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2019-08-20),

11. 10106536 - Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators (2018-10-23),

12. 9914708 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2018-03-13),

13. 9809590 - Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors (2017-11-07),

14. 9650376 - [object Object] (2017-05-16),

15. 9481653 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2016-11-01),

Title: The Innovative Journey of David A. Mareska

Introduction: David A. Mareska, a talented inventor hailing from McMurray, PA (US), has made significant contributions to the world of innovations with his creative mind and dedication.

Latest Patents: David A. Mareska holds several patents in various fields, showcasing his versatility and ingenuity in inventing new solutions to existing problems.

Career Highlights: Throughout his career, David A. Mareska has demonstrated a keen eye for identifying gaps in the market and developing groundbreaking inventions to fill those voids. His passion for innovation has led to the creation of several successful products that have improved the lives of many.

Collaborations: David A. Mareska has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in a team and leverage the expertise of others has been instrumental in the success of his projects.

Conclusion: In conclusion, David A. Mareska's journey as an inventor is a testament to his unwavering commitment to pushing the boundaries of what is possible through innovation. His impact on the world of inventions is truly remarkable, and his legacy will continue to inspire future generations of inventors.